- Hualu Hengsheng’s net income for the fiscal year was 3.58 billion yuan.
- The estimated net income was higher at 4.22 billion yuan, indicating a miss on estimates.
- The company’s revenue for the fiscal year was 27.26 billion yuan.
- Revenue also fell short of estimates, which were at 28.44 billion yuan.
- Despite the miss on estimates, there were 29 buys of Hualu Hengsheng’s stocks, with no holds or sells.
A look at Shandong Hualu Hengsheng A Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 5 | |
| Growth | 5 | |
| Resilience | 3 | |
| Momentum | 2 | |
| OVERALL SMART SCORE | 3.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Shandong Hualu Hengsheng A, a chemical manufacturing company, has a promising long-term outlook according to the Smartkarma Smart Scores. This innovative scoring system rates companies on a scale of 1-5, with higher scores indicating a better overall outlook. For Shandong Hualu Hengsheng A, the scores are 4 for value, 5 for dividend, 5 for growth, 3 for resilience, and 2 for momentum. This suggests that the company is well-positioned to provide investors with strong returns in the future.
Based on the company’s description, Shandong Hualu Hengsheng A specializes in the production of various chemical products, including urea, methanol, DMF, formaldehyde, and trimethylamine. With a high score of 5 for dividend, investors can expect to receive consistent and potentially increasing dividends from this company. Additionally, the company’s strong growth score of 5 indicates that it has the potential for significant expansion and profitability in the long run. However, with a lower score of 3 for resilience, there may be some risks associated with investing in this company. Overall, Shandong Hualu Hengsheng A shows great promise for long-term investors.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
